← All trials

NCT06843668

Phase 2/Phase 3Interventional

Trials that are a combination of phases 2 and 3.

View on ClinicalTrials.gov ↗

Timeline

Start date
Dec 25, 2023
Primary completion
Sep 25, 2025
Completion date
Oct 25, 2025
First posted
Feb 25, 2025
Last posted
Jul 4, 2025
Enrollment
120
Arms / groups
2 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.